Durable inhibition of ischemic complications by abciximab during percutaneous coronary revascularization: One-year results of the EPILOG trial

Journal Article

Full Text

Duke Authors

Cited Authors

  • Lincoff, AM; Tcheng, JE; Anderson, KM; Cabot, CF

Published Date

  • October 21, 1997

Published In

Volume / Issue

  • 96 / 8

Start / End Page

  • 902 - 902

International Standard Serial Number (ISSN)

  • 0009-7322